BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Amniocentesis
,
Tamoxifen
,
rs2230926
,
GATA1
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
beta 3 Subunit
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Cholinergic receptor nicotinic beta 3 subunit polymorphisms and smoking in male Chinese patients wit…
The genetic variant C825T of the beta 3 subunit of G protein is associated with hypertension in a Po…
A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype…
Neuronal Nav1.8 Channels as a Novel Therapeutic Target of Acute Atrial Fibrillation Prevention.
Mapping protein interactions of sodium channel NaV1.7 using epitope-tagged gene-targeted mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Child…
Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-…
A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and …
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ